• Aude Carlier, Ph.D., Co-founder, President, CEO & CSO
Aude Carlier holds a Ph.D. in Molecular Biology from the University of Nantes. She began her career on plant molecular biology and thereafter moving into the field of microalgal biotechnology, joining the laboratory of Dr. Jean-Paul Cadoret at the French Research Institute for Exploitation of the Sea (Ifremer). Aude developed global expertise in a broad field covering the genetic transformation of microalgae as well as upstream and downstream processes for the recovery of recombinant products, laying the foundation of Algenics.
In 2008, Aude co-founded Algenics and as CSO, has been central in conceiving and implementing the present strategy of Algenics. She currently oversees the progression of the various R&D programmes by directing a team of 14 skilled scientists.
In 2010, Aude was appointed CEO to strengthen the position of the company in the Biopharmaceutical sector.
• Jean-Paul Cadoret, Ph.D., Co-founder, SAB President
Jean-Paul Cadoret obtained his Ph.D. in Molecular Biology and Marine Biology and is recognized internationally as an expert in the exploitation of microalgae biotechnology. He brings over 20 years of research project management expertise in transgenesis of various organisms as well as microalgal physiology and design of innovative culture devices. Through his wide range of contacts, Jean-Paul also brings wider access to an extensive network of scientists in various fields of research and engineering.
He is currently Laboratory Director of Algae Physiology and Biotechnology at the French Research Institute for Exploitation of the Sea (Ifremer).
• Michel Conin
Michel Conin graduated from Audencia Business School (Nantes, France) and holds a master’s in Law. He began his career as an auditor for Coopers & Lybrand (now PricewaterhouseCoopers) therafter joining Barclays Bank France in their Mergers & Acquisitions department. In 1986 he bought the trading group Huet & Lanoë (1400 persons) in association with British Steel and Midland Bank. Following a positive turnaround within the group he sold the assets to British Steel and Poliet. Since then, as Huet Holdings (formerly Huet & Lanoë) President, he invested in multiple sectors. In 2008, Huet Holdings created Acta Alga, a fully-owned subsidiary to develop an innovative photobioreactor utilising artificial light sources for the industrial production of microalgae.
As an investor in the microalgal sector, Michel has a thorough understanding of the technical and commercial challenges and opportunities in this sector. He also brings many years of experience in various industries to Algenics.
